Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

A vaccine is a biological preparation that provides active acquired immunity to a particular infectious disease. Inactivated, attenuated, toxoid, subunit, conjugate, heterotypic, experimental, and valence are the types of vaccines.

U.S. vaccines market is estimated to account for US$ 19,355.2 Mn in terms of value in 2020 and is estimated to account for US$ 27,947.4 Mn by the end of 2027.

U.S. Vaccines Market: Drivers

Emergence of Covid-19 is expected to propel growth of the U.S. vaccines market over the forecast period. For instance, in the U.S. from January 20, 2020 to 6:01 pm CEST, 6 July 2020, there have been 2,833,552 confirmed cases of COVID-19 with 129,408 deaths, as reported to the World Health Organization.

Moreover, R&D initiatives for new vaccines is also expected to aid in growth of the market. For instance, in March 2020, IQVIA and Quest Diagnostics, through its joint venture Q2 Solutions, collaborated with the University of Texas Medical Branch to develop a novel assay for COVID-19 tests for rapid development of a Coronavirus vaccine.

Human vaccine held dominant position in the U.S. vaccines market in 2019, accounting for 81.7% share in terms of value, followed by animal vaccine respectively.

Figure 1. U.S. Vaccines Market Share (%), by Value, by Vaccine Type, 2019

U.S. Vaccine  | Coherent Market Insights

U.S. Vaccines Market: Restraints

High cost of refrigeration of vaccines is expected to hinder growth of the market. For vaccines, refrigeration is mandatory to prevent alteration of their chemical structure mainly due to contact with water and humidity resulting in ineffective medications. Maintaining this cold chain from production until they are used in treatment is a costly process accounting for about 80% of the price of vaccinations.

Moreover, short functional shelf life of certain vaccines is also expected to limit the market growth.

request-sample

U.S. Vaccines Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 18,367.0 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 5.4% 2027 Value Projection: US$ 27,947.4 Mn
Geographies covered:
  • U.S.
Segments covered:
  • By Product Type:
    • Human Vaccine: Pediatric Vaccines, Adult & Adolescent Vaccines, Other Human Vaccines.
    • Animal Vaccine: Livestock Vaccines, Companion Animal Vaccines, Other Animal Vaccines.
  • By End User: Hospitals, Clinics, Vaccination Centers.
Companies covered:

Sanofi Pasteur, GlaxoSmithKline Plc, Merck & Company Incorporated, Pfizer Incorporated, AstraZeneca plc, and Boehringer Ingelheim

Growth Drivers:
  • High prevalence of infectious diseases
  • Product launches
Restraints & Challenges:
  • Short functional shelf life of certain vaccines
  • High costs

U.S. Vaccines Market: Opportunities 

Building registry platform and database regarding COVID-19 is expected to offer lucrative growth opportunities for players in the U.S. vaccines market. For instance, in April 2020, Clara Health, a software startup, collaborated with Lyft, Inc., a ridesharing company, and VSC, a public relations agency, to build the registry platform and database to connect COVID-positive and -negative individuals with clinical trials for diagnostics, treatment and vaccine discovery.

Moreover, initiatives to promote R&D in poultry is also expected to aid in growth of the market.  For instance, in May 2020, The U.S. Poultry Foundation awarded a US$ 7,000 grant to the University of North Georgia to recruit students into the poultry science program.

U.S. vaccines market was valued at US$ 18,367.0 Mn in 2019 and is forecast to reach a value of US$ 27,947.4 Mn by 2027 at a CAGR of 5.4% between 2020 and 2027.

Figure 2. U.S. Vaccines Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

U.S. Vaccine  | Coherent Market Insights

Market Trends/Key Takeaways

Major players in the market are focused on adopting partnership and collaboration strategies to expand their product portfolio. For instance, in April 2020, Sanofi Pasteur collaborated with GSK to develop an adjuvanted vaccine for COVID-19.

Stringent regulations that promote vaccination are boosting the market growth. For instance, in January 2020,            the Government of New Jersey, U.S., mandated college students to be vaccinated against bacterial meningitis as a condition for attending an institution.

Regulations

The Center for Biologics Evaluation and Research (CBER) is the central regulatory agency responsible for ensuring purity, safety and efficacy of vaccines in the U.S.

U.S. Vaccines Market: Competitive Landscape

Major players operating in the U.S. vaccines market include, Sanofi Pasteur, GlaxoSmithKline Plc, Merck & Company Incorporated, Pfizer Incorporated, AstraZeneca plc, and Boehringer Ingelheim.

U.S. Vaccines Market: Key Developments

Major players in the market are focused on approval and launch of new vaccines to expand their product portfolio. For instance, in January 2020, Boehringer Ingelheim's U.S. Animal Health Business launched a vaccine, VAXXITEK HVT+IBD+ND that offers protection against Marek's Disease, Infectious Bursal Disease (classic and variant types) and Newcastle Disease.

Similarly, in December 2019,  NewLink Genetics Corporation received the U.S. FDA approval for ERVEBO or Zaire Ebola virus vaccine V920.

Vaccines are biologically prepared products, which provide active acquired immunity to diseases such as cholera, polio, rotavirus, smallpox, yellow fever and others. A vaccine comprise an agent resembling to the disease causing microorganism. The vaccines are generally developed from live attenuated or killed forms of the disease causing microorganism, its toxins, or its surface proteins.

Restraints of the U.S. Vaccine Market

Major factors hampering the growth of the U.S. vaccine market during the forecast period constitutes of short functional shelf life of certain vaccines, and high costs.

Key features of the study:

  • This report provides in-depth analysis of the U.S. vaccine market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the U.S. vaccine market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
  • Key companies covered as a part of this study include Sanofi Pasteur, GlaxoSmithKline Plc, Merck & Company Incorporated, Pfizer Incorporated, AstraZeneca plc, and Boehringer Ingelheim.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The U.S. vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the assistive reproductive technology market.

Detailed Segmentation

  • U.S. Vaccine Market, By Product Type:
    • Human Vaccine
      • Pediatric Vaccines
      • Adult & Adolescent Vaccines
      • Other Human Vaccines
    • Animal Vaccine
      • Livestock Vaccines
      • Companion Animal Vaccines
      • Other Animal Vaccines
  • U.S. Vaccine Market, By End User:
    • Hospitals
    • Clinics
    • Vaccination Centers
  • Company Profiles
    • Sanofi Pasteur *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • GlaxoSmithKline Plc
    • Merck & Company Incorporated
    • Pfizer Incorporated
    • AstraZeneca plc
    • Boehringer Ingelheim

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By End User
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Technological Advancement
    • Regulatory Scenario
  4. U.S. Vaccine Market, By Product Type, 2017 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • Human Vaccine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
        • Pediatric Vaccines
        • Adult & Adolescent Vaccines
        • Other Human Vaccines
    • Animal Vaccine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
        • Livestock Vaccines
        • Companion Animal Vaccines
        • Other Animal Vaccines
  5. U.S. Vaccine Market, By End User, 2017 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Vaccination Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
  6. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Sanofi Pasteur
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • GlaxoSmithKline Plc
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Merck & Company Incorporated
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Pfizer Incorporated
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • AstraZeneca plc
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Boehringer Ingelheim
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  7. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 37 market data tables and 25 figures on “Vaccines Market – U.S. forecast to 2027.

Frequently Asked Questions

The U.S. vaccine market was valued at US$ 18,367.0 Mn in 2019 and is forecast to reach a value of US$ 27,947.4 Mn by 2027 at a CAGR of 5.4% between 2020 and 2027.
Major factor driving the growth of U.S. vaccine market during the forecast period include high prevalence of infectious diseases, and product launches.
Major factors hampering the growth of the U.S. vaccine market during the forecast period constitutes of short functional shelf life of certain vaccines, and high costs.
Human vaccines held dominant position in the U.S. vaccine market in 2019.
Pediatric Vaccines is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are Sanofi Pasteur, GlaxoSmithKline Plc, Merck & Company Incorporated, Pfizer Incorporated, AstraZeneca plc, and Boehringer Ingelheim.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner